文献速递骨质疏松与钙磷/甲状旁腺

非典型股骨骨折或其他低磷酸酯酶症生化与临床征象患者的ALPL基因型

ALPL Genotypes in Patients With Atypical Femur Fractures or Other Biochemical and Clinical Signs of Hypophosphatasia.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

该研究回顾性纳入3个欧洲骨科中心的106例疑似成人低磷酸酯酶症(HPP)患者进行ALPL基因检测,在2.8%初步怀疑骨质疏松的病例中检出杂合罕见变异;发生非典型股骨骨折(AFF)者常见ALPL变异纯合子比例达30.8%,且血清总碱性磷酸酶活性正常。结果提示常见ALPL变异纯合可能是此类骨折的遗传风险标志。

要点

  • 对106例疑似成人HPP患者行ALPL基因检测,2.8%的初诊疑似骨质疏松者检出杂合罕见变异。
  • 发生AFF者中ALPL常见变异纯合子比例为30.8%,伴血清总ALP活性正常。
  • 作者认为常见ALPL变异纯合可能是AFF的遗传风险标志。

核心结论

  • 结果提示常见ALPL变异纯合可能是这些骨折的遗传风险标志。

研究设计与样本

  • 回顾性选取3个欧洲骨科中心(佛罗伦萨、那不勒斯和日内瓦)的106例有提示轻度HPP生化或临床征象的疑似成人HPP患者进行ALPL基因检测。

主要发现

  • 基因检测在2.8%最初被转诊为疑似骨质疏松的病例中检出杂合罕见变异。
  • 在发生AFF且血清总ALP活性正常的受试者中,ALPL常见变异纯合子比例为30.8%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Hypophosphatasia (HPP) is a rare metabolic disorder caused by deficiency of alkaline phosphatase (ALP) enzyme activity, leading to defective mineralization, due to pathogenic variants of the ALPL gene, encoding the tissue nonspecific alkaline phosphatase (TNSALP) enzyme. Inheritance can be autosomal recessive or autosomal dominant. An abnormal ALPL genetic test enables accurate diagnosis, avoiding the administration of contraindicated antiresorptive drugs that, in patients with HPP, substantially increase the risk of atypical femur fractures (AFFs) and worsen the fracture healing process that is usually already compromised in these patients. OBJECTIVE: Performing ALPL genetic testing to identify rare variants in suspected adult patients with HPP. Comparing frequencies of ALPL common variants in individuals with biochemical and/or clinical signs suggestive of adult HPP and non-HPP controls, and among different clinical subgroups of patients with a clinical suspicion of adult HPP. METHODS: Patients with suspected adult HPP were retrospectively selected for the genetic testing of the ALPL gene. Patients included were from 3 main European Bone Units (Florence, Naples, and Geneva); 106 patients with biochemical and/or clinical signs suggestive of a mild form of HPP were included. RESULTS: Genetic testing led to the identification of a heterozygote rare variant in 2.8% of cases who were initially referred as suspected osteoporosis. The analysis of frequencies of ALPL common variants showed a high prevalence (30.8%) of homozygosity in subjects who developed an AFF, in association with normal serum total ALP activity. CONCLUSION: The results suggest homozygosity of common ALPL variants as a possible genetic mark of risk for these fractures.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Marini F, Masi L, Giusti F, et al. ALPL Genotypes in Patients With Atypical Femur Fractures or Other Biochemical and Clinical Signs of Hypophosphatasia. J Clin Endocrinol Metab. 2022. PMID: 34935951. doi:10.1210/clinem/dgab914

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。